ArticleJapanese journal of radiology2015
Diffusion-weighted MRI in a case of nonsuppressing rebound thymic hyperplasia on chemical-shift MRI.
Article in Japanese journal of radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 12 citations in OpenAlex.
- A Thymic Hyperplasia Case without Suppressing on Chemical Shift Magnetic Resonance Imaging.Case reports in radiology · 2018Article
- Rebound thymic hyperplasia after bone marrow transplantation in children with haemato-oncological diseases.Contemporary oncology (Poznan, Poland) · 2018Article
- The Value of CT and MRI for Determining Thymoma in Patients With Myasthenia Gravis.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rebound thymic hyperplasia (RTH) generally retains the quadrilateral or triangular shape typical of the normal thymus. Nevertheless, RTH may rarely appear as a focal mass, a condition that mimics tumors if reveals soft tissue attenuation at computed tomography (CT). In such cases, chemical-shift magnetic resonance imaging (MRI) can demonstrate microscopic fat within tissue, that would be indistinct at CT, by showing signal suppression on opposed-phase images relative to in-phase images, although two cases of nonsuppressing thymus have been described in early adulthood, both of them with minimally fat amount at histology, but none with RTH. Albeit diffusion-weighted MRI could be helpful in cases of nonsuppressing RTH at chemical-shift MRI, considering its capability in differentiating benign from malignant lesions, currently, no data are available on its use in such cases. Hereby, we report a case of atypical RTH at CT with no signal suppression on chemical-shift MRI, arose after corticosteroid treatment for mixed cryoglobulinemia in a 60-year-old woman. Diffusion-weighted MRI demonstrated unrestricted diffusion, as generally seen for benign tissue with no cellular atypia, and thus was helpful to differentiate RTH from malignant mediastinal tumors, especially from B cell lymphoma related to type II cryoglobulinemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.